Amrize (NYSE:AMRZ) CFO Acquires $250,495.00 in Stock

Amrize Ltd (NYSE:AMRZGet Free Report) CFO Ian Johnston bought 4,250 shares of the firm’s stock in a transaction dated Tuesday, March 10th. The stock was bought at an average cost of $58.94 per share, with a total value of $250,495.00. Following the transaction, the chief financial officer directly owned 25,110 shares of the company’s stock, valued at approximately $1,479,983.40. This trade represents a 20.37% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.

Amrize Price Performance

AMRZ stock opened at $55.51 on Friday. The firm has a market cap of $30.70 billion and a P/E ratio of 22.56. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $65.94. The stock has a 50-day simple moving average of $57.93 and a 200-day simple moving average of $53.67.

Amrize (NYSE:AMRZGet Free Report) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.59 by $0.03. The company had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.95 billion. Amrize’s revenue was down .4% on a year-over-year basis.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Bank of America set a $58.00 target price on shares of Amrize in a research note on Monday, January 12th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $70.00 price target on shares of Amrize in a research note on Thursday, December 18th. Royal Bank Of Canada boosted their price objective on shares of Amrize from $60.00 to $61.00 and gave the stock a “sector perform” rating in a report on Thursday, February 19th. UBS Group upped their price objective on shares of Amrize from $53.00 to $57.00 and gave the company a “neutral” rating in a research report on Thursday, January 8th. Finally, Wall Street Zen upgraded Amrize from a “sell” rating to a “hold” rating in a research note on Sunday, March 1st. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $64.14.

Check Out Our Latest Report on AMRZ

Institutional Trading of Amrize

A number of hedge funds have recently made changes to their positions in the stock. MCF Advisors LLC bought a new stake in shares of Amrize in the fourth quarter worth $27,000. Basepoint Wealth LLC bought a new position in Amrize during the 4th quarter valued at $33,000. Laurel Wealth Advisors LLC bought a new position in Amrize during the 4th quarter valued at $34,000. State of Wyoming acquired a new position in Amrize during the 3rd quarter worth $32,000. Finally, Itau Unibanco Holding S.A. grew its holdings in Amrize by 150.0% during the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after acquiring an additional 450 shares in the last quarter.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Insider Buying and Selling by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.